Artificial intelligence hides winners in ‘failed’ Alzheimer’s drug trial
After researchers used artificial intelligence to divide patients into fast, slow disease progressers, an allegedly unsuccessful Alzheimer’s drug trial achieved surprising results, which reduced cognitive decline in a group by 46%. The findings, published...